the data available to date show : there is no risk of teratogenic effects , the qt interval is prolonged during infancy ( no associated arrhythmias noted ) , infant bradycardia occurs and should be monitored and thyroid function can be affected and should be monitored at birth .
C0003811
arrhythmias
C0428977
bradycardia